aTyr Pharma (LIFE) Reports Manufacturing Agreement with Lonza for Anti-NRP2 Antibody ATYR2810 Apr 14, 2021 08:04AM
aTyr Pharma and Lonza Announce Manufacturing Agreement for aTyr’s Anti-NRP2 Antibody ATYR2810 Apr 14, 2021 08:00AM
PJSC Pharmsynthez Completes Follow Up and Data Analysis From a Phase 2 Study of Novel Therapeutic Vaccine Xemys(TM) for Multiple Sclerosis Apr 1, 2016 08:14AM
Pre-Open Stock Movers 1/17: (NIHD) (ARQL) (TWTR) Higher; (SSNI) (RDEN) (AAWW) Lower (more...) Jan 17, 2014 09:34AM
After Hours Stock Movers 1/16: (ARQL) (SWKS) (TSCO) Higher; (RDEN) (FCEL) (BJRI) Lower (more...) Jan 16, 2014 06:02PM